000	02116cam  2200373zi 4500
001	9.868973
003	CaOODSP
005	20221107162731
006	m     o  d f
007	cr |||||||||||
008	190227t19921992oncd    ob   f000 0 eng d
020	|z0660144379
040	|aCaOODSP|beng|erda|cCaOODSP
043	|an-cn-on
086	1 |aEC22-183/1992E-PDF|zEC22-183/1992E
100	1 |aGorecki, Paul K., |d1948- |eauthor.
245	10|aControlling drug expenditure in Canada : |bthe Ontario experience / |cPaul K. Gorecki.
246	30|aOntario experience
264	1|a[Ottawa] : |bEconomic Council of Canada, |c1992.
264	4|c©1992
300	|a1 online resource (xi, 160 pages) : |bcharts.
336	|atext|btxt|2rdacontent
337	|acomputer|bc|2rdamedia
338	|aonline resource|bcr|2rdacarrier
500	|a"A study published by the Economic Council of Canada and the Ontario Ministry of Health."
504	|aIncludes bibliographic references.
520	|a"The study raises a broad range of issues concerning the management of drug programs, from the merits of alternative forms of user charges and the appropriate mechanism for setting the pharmacist's dispensing fee, to the virtues of different drug pricing systems. Insights into the behaviour and motivation of pharmacists, physicians, generic and brandname drug firms, and consumers are drawn upon in discussing these issues. Irrespective of whether the study's preferred options are implemented, it will enable a greater appreciation and understanding of the forces that help to shape provincial drug programs. As such, it will foster constructive dialogue and improved policy making"--Foreword, page xi.
692	07|2gccst|aPrescription drugs
692	07|2gccst|aPharmaceutical industry
692	07|2gccst|aPricing
710	1 |aOntario.|bMinistry of Health.
710	2 |aEconomic Council of Canada.
776	0#|tControlling drug expenditure in Canada: the Ontario experience / |w(CaOODSP)9.644543
856	40|qPDF|s20.27 MB|uhttps://publications.gc.ca/collections/collection_2019/ecc/EC22-183-1992-eng.pdf